News/ News/ R&D Entresto tops mainstay ACE inhibitor in heart failure trial Phil Taylor Entresto, heart failure drug, Novartis 0 Comment Two years ago, Novartis launched a big trials programme for its heart failure drug Entresto in the hope Share X Entresto tops mainstay ACE inhibitor in heart failure trial https://pharmaphorum.com/news/entresto-tops-mainstay-ace-inhibitor-in-heart-failure-trial/
